BackXTL Biopharmaceuticals Overview

XTL Biopharmaceuticals Goodwill

XTL Biopharmaceuticals's goodwill is $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00
↓ 100.00% YoYΔ $-3.19M vs prior year quarter

Peer trimmed avg / median

Loading

XTL Biopharmaceuticals Goodwill History

Loading

XTL Biopharmaceuticals vs. peers: Goodwill Comparison

Loading

XTL Biopharmaceuticals Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

XTL Biopharmaceuticals (XTLB.TA) FAQ

As of the most recent data (December 2025), XTLB.TA shows a goodwill of $0. That compares with $3.2M in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, XTLB.TA's goodwill is now $0 (was $3.2M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether XTL Biopharmaceuticals is outperforming or lagging.

Tracking XTLB.TA's goodwill over time shows whether XTL Biopharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $3.2M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has XTL Biopharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $0) with ownership activity and broader fundamentals.

XTL Biopharmaceuticals's goodwill is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.